Patent details

Basic Information

Publication number:

EP1976529

PCT Application Number:

PCT/US/2007/001365

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP077628311

PCT Publication Number:

WO/2007/089445

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANG2 AND VEGF INHIBITOR COMBINATIONS

French Title of Invention:

COMBINAISONS D'INHIBITEURS D'ANG2 ET DE VEGF

German Title of Invention:

ANG2- UND VEGF-HEMMERKOMBINATIONEN

SPC Number:

Dates

Filing date:

19/01/2007

Grant date:

11/12/2013

EP Publication Date:

11/12/2013

PCT Publication Date:

09/08/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/10/2008

EP B1 Publication Date:

11/12/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/01/2014

Expiration date:

19/01/2027

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

19/01/2007

 

 

Name:

Amgen Inc.

Address:

One Amgen Center Drive M/S 28-2-C, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:

OLINER Jonathan

Address:

United States (US)

2

Name:

KENDALL Richard

Address:

United States (US)

3

Name:

KUMAR Rakesh

Address:

United States (US)

Priority

Priority Number:

762493 P

Priority Date:

27/01/2006

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/435;

Filing date	Document type	Number of pages